CION Ameerpet
Immunotherapy Side Effects · Steroids & Managing Immune Reactions
Will Immunotherapy Be Stopped Permanently — After a Reaction?
A confirmed immune reaction to immunotherapy doesn't automatically mean your treatment is over. Oncology teams use a standard 1-to-4 severity grading system, referenced by NCCN and ASCO, to decide whether to continue, pause, or permanently stop treatment — and most reactions fall into the grades that allow treatment to continue or resume. This page explains exactly what decides that outcome.
Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed August 2026
- Most reactions don't end treatment — the majority are graded mild to moderate, and immunotherapy continues or resumes once treated.
- A grading system decides, not guesswork — your oncology team uses a standard severity scale to decide the next step.
- Steroids used to treat a reaction don't cancel the benefit — current guidance says they haven't been shown to meaningfully reduce immunotherapy's effect.
- Only the most severe reactions usually mean stopping for good — specific organs, like the heart, are treated with extra caution.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Straight answer first
Will This Reaction End Your Immunotherapy for Good?
If you are unwell right now, this page is not the place to manage it:
If you have severe or worsening symptoms at this moment — severe diarrhoea, breathlessness, chest pain, confusion, or collapse — call the helpline or go to the nearest emergency room immediately. Everything below explains what happens once a reaction has already been assessed and treated, not what to do in the middle of one.
Call the CION Helpline Now: 1800 202 8726No — most immune-related reactions do not stop immunotherapy for good. What happens next depends on how severe the reaction was and which organ it affected, graded on a standard 1-to-4 scale your oncology team uses to decide whether to continue, pause, delay, or permanently stop treatment. Only the most severe grade, or reactions affecting organs such as the heart, usually lead to a permanent stop.
The system behind the decision
What Grade Stops It? The Scale Your Oncology Team Actually Uses
Oncology teams grade every immune-related reaction from 1 (mild) to 4 (life-threatening) using CTCAE criteria, a scale referenced in NCCN and ASCO immune-related adverse event guidance. The grade — not how frightening the symptom feels in the moment — is what decides whether immunotherapy continues, is held, or is stopped.
| Grade | What it generally means | Usual effect on immunotherapy |
|---|---|---|
| Grade 1 — Mild | Symptoms are mild, often picked up on a blood test or on close questioning rather than something you'd notice unprompted. | Immunotherapy usually continues on schedule, with closer monitoring. |
| Grade 2 — Moderate | Symptoms affect daily activities but aren't dangerous by themselves. | Immunotherapy is usually paused until symptoms settle, often alongside steroid treatment. |
| Grade 3 — Severe | Symptoms are severe or medically significant and often need hospital-level care. | Immunotherapy is held immediately and steroids are started; restarting is assessed individually once the reaction resolves. |
| Grade 4 — Life-threatening | The reaction is life-threatening, or the affected organ is failing. | Immunotherapy is usually stopped permanently, especially when the heart or nervous system is involved. |
These are general patterns, not a fixed rule for every case. Your oncologist grades your specific reaction and decides your next step — never estimate your own grade from symptoms alone.
Did you know?
Many patients who pause immunotherapy for a Grade 2 or Grade 3 reaction are able to resume treatment once the reaction has fully settled and the steroid dose has been tapered down, under close monitoring — a pause is not automatically the same as stopping for good. (Source: NCCN / ASCO immune-related adverse event management guidelines.)
The usual sequence
Is It Always Permanent? What Typically Happens After a Reaction
For most confirmed reactions, immunotherapy is held rather than stopped outright. Your team treats the reaction — often starting with a steroid course that is increased if needed and then reduced gradually once symptoms are under control — and reassesses whether to restart once you have recovered and the steroid dose has come down to a safe level.
This process can take anywhere from a few weeks to a couple of months, depending on the organ involved and how you respond to treatment. A hold is not a stop: your oncology team revisits the decision at each step rather than assuming the answer in advance.
Never reduce, stop, or restart a steroid dose on your own, even if you feel completely well — tapering is planned by your care team, and sudden changes can be unsafe.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Questions About Restarting or Stopping Immunotherapy?
Our tumour board reviews every case individually — reach the team managing decisions like this one.
Restarting after a hold
What Decides Whether You Can Restart (Rechallenge)?
Restarting immunotherapy after a reaction — called rechallenge — is never a single-factor decision. Your oncology team weighs several things together before deciding whether the benefit of continuing outweighs the risk of the reaction coming back.
- 1
Which organ was affected, and how severe it was
A mild skin or thyroid reaction is judged very differently from one involving the heart, lungs, or nervous system.
- 2
How completely the reaction resolved
Your team confirms symptoms and relevant test results have returned to a safe baseline before considering a restart.
- 3
How far the steroid dose has been tapered
Rechallenge is generally only considered once the steroid dose has come down to a low, stable level, not while it is still being reduced.
- 4
How your cancer is responding overall
Scans and markers showing a strong response can shift the balance toward trying a careful restart; early disease progression may not.
- 5
Your own preference
Some patients, after understanding the risk of recurrence, choose not to restart even when it is medically possible — that choice is respected and discussed openly.
When it doesn't restart
Which Reactions Usually Lead to Stopping for Good?
A smaller group of reactions are treated as a permanent stop rather than a pause, because the risk of the same reaction recurring — and being worse the second time — is considered too high.
- Grade 4, life-threatening reactions of any type
- Immune-related heart inflammation (myocarditis), regardless of grade, because recurrence can be more dangerous the second time
- Certain severe neurological reactions, such as significant nerve or muscle weakness affecting breathing or swallowing
- A repeat reaction after an earlier rechallenge, in most cases
- Your own informed decision not to continue, after discussing the risks with your team
The fear behind the question
Does Stopping Undo the Benefit Immunotherapy Already Gave You?
Not necessarily. The anti-cancer immune response an immunotherapy drug has already triggered can continue working for a period even after the drug itself is paused or stopped — this is part of why oncology teams don't treat every hold as a crisis for your cancer control. Your scans and bloodwork are monitored closely during any pause specifically to check this, so any change is caught early rather than assumed.
This is different from a steroid course given to treat the reaction itself — current NCCN and ASCO guidance is that steroids used this way haven't been shown to meaningfully reduce immunotherapy's anti-cancer effect either.
Care through the reaction, not just around it
Decisions About Your Treatment Are Never Made Alone
A multidisciplinary tumour board reviews every hold, restart, and stop decision case by case.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Stopping, Pausing and Restarting Immunotherapy: Your Questions Answered
Will immunotherapy be stopped for good after an immune reaction?
No, not usually. Most confirmed immune-related reactions are graded mild to moderate, and immunotherapy either continues on schedule or is paused temporarily until the reaction settles. Only the most severe reactions, or ones affecting certain organs such as the heart or nervous system, typically lead to permanently stopping treatment. Your oncology team makes this decision case by case, based on the reaction's grade and how you respond to treatment, not as a blanket rule.
What grade of reaction stops immunotherapy?
Oncology teams use the CTCAE scale, referenced in NCCN and ASCO immune-related adverse event guidance, which grades reactions from 1 (mild) to 4 (life-threatening). Grade 1 reactions usually allow immunotherapy to continue with closer monitoring. Grade 2 and Grade 3 reactions usually mean immunotherapy is held while the reaction is treated, often with steroids, and reassessed afterwards. Grade 4 reactions, and specific organ involvement such as the heart, most often lead to permanently stopping treatment.
What decides whether you can restart immunotherapy (rechallenge)?
Restarting, known as rechallenge, is decided on several factors together: which organ was affected and how severe the reaction was, how completely it resolved, how far the steroid dose has been safely tapered down, and how your cancer is otherwise responding to treatment. Your oncology team, often through a tumour board discussion, weighs the benefit of continuing immunotherapy against the risk of the reaction recurring before deciding, and involves you in that conversation.
Which reactions usually lead to permanently stopping immunotherapy?
Grade 4, life-threatening reactions are the clearest case for permanently stopping treatment. Certain organs are also treated with extra caution regardless of grade — immune-related heart inflammation (myocarditis) and some severe neurological reactions are typically not restarted because the risk of recurrence is considered too high. Some patients also choose, after discussion with their team, not to restart even when medically possible, and that choice is respected.
Does pausing immunotherapy for a reaction let the cancer come back?
Not necessarily. The anti-cancer immune response an immunotherapy drug has already triggered can continue working for a period even while the drug itself is paused or stopped, which is part of why oncology teams don't treat every hold as an emergency. Your scans and bloodwork are monitored closely during any pause specifically to check this, and your team will discuss next steps with you if the picture changes.
Can I stop or adjust my steroid dose myself once I feel better?
No. Never stop or change your steroid dose without your oncology team's direct instruction, even once symptoms feel completely resolved. Steroid doses used to treat immune reactions are reduced gradually on a planned schedule, and stopping suddenly after more than a couple of weeks of treatment can be unsafe. Always follow your care team's exact tapering plan and call them with any questions rather than adjusting the dose on your own.